npj Parkinson s DiseaseGenetic & Genomic MedicinePeer-reviewed journal article
TMEM175, SCARB2 and CTSB associations with Parkinson's disease risk across populations.
Wenhua Sun, Claudia SchulteiD, Thomas GasseriD, Manuela M. X. TaniD, the Global Parkinson’s Genetic Program (GP2), Lasse PihlstrømiD, Pedro Chaná, Yeajin Song, Sara Bandrés‐CigaiD, Cornelis BlauwendraatiD, Andrew SingletoniD, Mike A. NallsiD, Hampton L. LeonardiD, Mie RizigiD, Hirotaka IwakiiD, Carlos Roberto de Mello RiederiD, Ignacio Fernandez MataiD, Njideka Ulunma OkubadejoiD, Emilia Mabel GattoiD, Marcelo Andrés KauffmaniD, Claire E. ShepherdiD, Samson G. KhachatryaniD, Zaruhi D. TavadyaniD, Julie Hunter, Kishore Raj KumariD, , Rejko KrügeriD
Abstract
Genome-wide association study of Parkinsons disease (PD) identified common variants associated with lysosomal mechanism, including TMEM175, SCARB2, and CTSB. We investigated the association between common and rare variants across populations using cohorts from the Global Parkinsons Genetics Program (GP2) (33,813 cases and 18,714 controls from 11 ancestries), and the Accelerating Medicines Partnership Parkinsons Disease (AMP-PD) whole genome sequencing (3,188 cases and 4,104 controls). In the European cohort, we confirmed significant associations with PD risk for all known genetic risk variants across the three genes and TMEM175 p.M393T as an independent genome-wide significant signal. Additionally, a novel independent signal, SCARB2 rs11547135, was detected. The burden analysis linked PD to SCARB2 in African American, Ashkenazi Jewish and East Asian cohorts. Single variants-based tests identified rare missense and synonymous variants in SCARB2 in several populations. Our study reinforces the association of lysosomal genetic variants with PD risk, revealing genetic heterogeneity across populations.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 5
- FWCI
- 3.02
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic modifiers of risk and age at onset in GBA associated Parkinson disease and Lewy body dementia
Cornelis Blauwendraat, Xylena Reed, … Andrew Singleton·BrainPeer-reviewed·Oct 23, 2019
- Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes
Isabel Alfradique‐Dunham, Rami Al‐Ouran, … Joshua M Shulman·Neurology GeneticsPeer-reviewed·Apr 1, 2021
- Whole-genome sequencing of 197 cases with Parkinson's Disease reveals novel pathogenic variants in the Indian population
Hiba Ali, Banashree Mondal, … Shweta Ramdas·npj Parkinson s DiseasePeer-reviewed·Jul 6, 2026
- Parkinson disease age of onset GWAS: defining heritability, genetic loci and a-synuclein mechanisms
Cornelis Blauwendraat, Karl Heilbron, … Andrew Singleton·Movement DisordersPeer-reviewed·Apr 7, 2019
- Genomic Landscape of Early-Onset and Familial Latin American Parkinson's Patients
Emily Waldo, Henry Mauricio Chaparro-Solano, … Ignacio Fernandez Mata·medRxiv·Sep 22, 2026
- The Global Landscape of Genetic Variation in Parkinson's disease: Multi-Ancestry Insights into Established Disease Genes and their Translational Relevance
Lara Mariah Lange, Zih‐Hua Fang, … the Global Parkinson’s Genetic Program (GP2)·medRxiv·Jul 8, 2025